MEN2B is characterized by the more aggressive forms of MTC, with higher riskpathogenic variants of ATA risk level and disease onset in the first decade of life.Reports of malignancy shortly after birth, notably with M918T pathogenic variantscause treatment difficulties in many health settings. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.